Novellia Inc. raises $18M in Series A

Novellia Inc., a health data startup focused on patient-controlled medical records, secured $18 million in a Series A funding round led by Spark Capital. The funds will fuel the scaling of its platform designed to allow patients to consolidate and share their health records with pharmaceutical firms for research purposes. The fundraising also facilitated the launch of a new patient-facing mobile app, enhancing accessibility to Novellia's services via smartphone.

Distinct from traditional health data aggregation models that rely on insurance claims and hospital records, Novellia offers a patient-centric approach. Its platform can amalgamate up to 20 years of medical history from various U.S. healthcare providers in under 30 seconds. The system primarily targets individuals with complex health conditions, integrating advanced natural language processing to convert unstructured clinical text, such as doctor's notes and lab reports, into useful, de-identified datasets for drug companies.

Several top pharmaceutical companies have already adopted Novellia's platform, with the firm securing seven-figure multi-year contracts following this funding round. Co-founder and CEO Shashi Shankar emphasized the transformative potential of their approach by addressing the fragmentation in current medical data systems and leveraging personal experience within the pharmaceutical industry.

The investment marks an expansion in patient-controlled data usage, suggesting a shift in how health information is leveraged for research. With a health data market exceeding $50 billion annually, Novellia aims to redefine the sector by prioritizing patient engagement and consent. The involvement of investors such as Spark Capital and Khosla Ventures underscores the industry's recognition of this evolving model.

Looking ahead, Novellia's expansion will likely focus on broadening its market reach and enhancing its technology. As regulatory landscapes around data privacy continue to evolve, maintaining compliance while expanding partnerships with drug manufacturers will be critical. The completed funding round brings Novellia's total investment to $28 million, positioning the company for strategic growth in the competitive health data sector.